Učitavanje...
Glucagon‐like peptide analogues for type 2 diabetes mellitus
BACKGROUND: Glucagon‐like peptide analogues are a new class of drugs used in the treatment of type 2 diabetes that mimic the endogenous hormone glucagon‐like peptide 1 (GLP‐1). GLP‐1 is an incretin, a gastrointestinal hormone that is released into the circulation in response to ingested nutrients. G...
Spremljeno u:
| Izdano u: | Cochrane Database Syst Rev |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Ltd
2011
|
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486297/ https://ncbi.nlm.nih.gov/pubmed/21975753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006423.pub2 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|